Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical versus systemic ibandronic acid to improve prosthesis fixation and periprosthetic bone density after knee arthroplasty
2006-003748-43Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ibandronic acid in knee osteoarthritis (OA) (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Periprosthetic bone mineral density by DEXA. Started Oct 2006; status: completed.
02
Drugs
ibandronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-003748-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003748-43.